NCT04492410View on ClinicalTrials.gov

COVID-19 Infection Screening in Cancer Patients (NEOSCREENCOVID)

NACompletedINTERVENTIONAL
Enrollment

214

Participants

Timeline

Start Date

July 21, 2020

Primary Completion Date

May 12, 2021

Study Completion Date

November 12, 2021

Conditions
Cancer
Interventions
OTHER

rapid serological test

screening using a rapid serological test with a drop of blood from a finger prick

Trial Locations (1)

06189

Centre Antoine Lacassagne, Nice

All Listed Sponsors
lead

Centre Antoine Lacassagne

OTHER

NCT04492410 - COVID-19 Infection Screening in Cancer Patients (NEOSCREENCOVID) | Biotech Hunter | Biotech Hunter